Papaverine Hydrochloride 30 mg / mL Injection 2 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 00517-4002-25 |
|---|---|
| Product NDC | 00517-4002 |
| Generic Drug Name | Papaverine Hydrochloride |
| Brand Name | Papaverine Hydrochloride |
| Manufacturer | American Regent, Inc. |
| Strength | 30 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 25 Vial |
| Package Description | 25 VIAL in 1 CARTON (0517-4002-25) / 2 mL in 1 VIAL (0517-4002-01) |
| Active Ingredients | Papaverine Hydrochloride |
| Marketing Category | UNAPPROVED DRUG OTHER |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Papaverine Hydrochloride 30 mg / mL Injection is tracked under NDC 00517-4002-25 and rolls up into product family 00517-4002. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 25 Vial.
- Manufacturer: American Regent, Inc..
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources show a public shortage notice for the exact NDC and exact-product labeling references for Papaverine Injection 00517-4002-25.
Drug Shortage Index family
View Papaverine Hydrochloride in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Papaverine Hydrochloride.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Papaverine Hydrochloride 30 mg / mL Injection 2 mL, NDC 00517-4002-25, is a American Regent, Inc. 30 mg / mL injection presentation packaged as 25 Vial. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 00517-4002-25.
- Digits-only NDC 11: 00517400225.
- Possible 10-digit display format: 0517-4002-25 (0517400225).
Helpful product links
- Search by brand name: Papaverine Hydrochloride.
- Exact NDC 11: 00517-4002-25.
- Product family NDC: 00517-4002.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.